Amrutanjan Health Care (Small Cap) Share Target 2025, 2026 To 2035
|
Amrutanjan Health Care Limited |
|||
|
Price: ₹598.40 (+0.11%) | ||
| 52 Week Low: ₹586.40 52 Week High: ₹862.60 |
|||
| Market Capital: 1,926.88 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Amrutanjan Health Care Share Price Target For 2025
- 1.1.1: Amrutanjan Health Care Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Amrutanjan Health Care Share Price Target For 2026
- 1.2.1: Amrutanjan Health Care Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Amrutanjan Health Care Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Amrutanjan Health Care Brief Company Overview
- 4: Amrutanjan Health Care Financial Performance
- 4.0.1: Is Amrutanjan Health Care A Good Buy For Long Term?
Amrutanjan Health Care, a Small Cap company in the Drug Manufacturers - Specialty & Generic Industry has delivered 33.1% returns in 5-year showing 7.5% quarterly revenue growth with 10.0% profit margin.
To predict the Amrutanjan Health Care's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Amrutanjan Health Care Share Price Target For 2025
The line chart displays the monthly closing prices of Amrutanjan Health Care with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Amrutanjan Health Care shares in 2025, see the table below.
Amrutanjan Health Care Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 654.09 (+9.3%) | Price Action: 23 Feb 2024 Low |
| 2025 Target 2 | 646.8 (+8.08%) | Price Action: 10 Feb 2025 Low |
| 2025 Target 1 | 639.25 (+6.82%) | Price Action: 04 Feb 2025 Low |
| Current Price | 598.40 | Amrutanjan Health Care's share price as of 21 Feb 2025 |
| Stop Loss 1 | 578.96 (-3.25%) | Price Action: 11 Jan 2024 Low |
| Stop Loss 2 | 572.25 (-4.37%) | Price Action: May 2023 Low |
| Stop Loss 3 | 566.44 (-5.35%) | Price Action: Feb 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Amrutanjan Health Care is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹651.67 serves as the nearest technical reference point.
Historical Returns: 3-month: -18.91% | 6-month: -26.58% | 1-year: -5.96%
Amrutanjan Health Care Share Price Target For 2026
The line chart displays the monthly closing prices of Amrutanjan Health Care with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Amrutanjan Health Care shares in 2026, see the table below.
Amrutanjan Health Care Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 796.22 (+33.04%) | Price Action: 02 Jul 2024 High |
| 2026 Target 2 | 786.27 (+31.39%) | Price Action: 10 Jul 2024 High |
| 2026 Target 1 | 778.3 (+30.06%) | Price Action: 12 Sep 2024 Low |
| Current Price | 598.40 | Amrutanjan Health Care's share price as of 21 Feb 2025 |
| Stop Loss 1 | 547.4 (-8.52%) | Price Action: Mar 2023 Low |
| Stop Loss 2 | 538.31 (-10.05%) | Price Action: Feb 2020 High |
| Stop Loss 3 | 532.83 (-10.96%) | Price Action: Apr 2021 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Amrutanjan Health Care is currently trading near its 52-week low of ₹586.4, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -5.96% | 3-year: -27.04% | 5-year: +33.14%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Amrutanjan Health Care Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹598.40 | ||
| 2025 | ₹923.39 | +54.3% | ₹937.24 |
| 2026 | ₹1,074.74 | +16.39% | ₹1,090.86 |
| 2027 | ₹1,160.04 | +7.93% | ₹1,177.44 |
| 2028 | ₹1,248.80 | +7.65% | ₹1,267.53 |
| 2029 | ₹1,319.11 | +5.63% | ₹1,338.90 |
| 2030 | ₹1,336.64 | +1.32% | ₹1,356.69 |
| 2031 | ₹1,511.56 | +13.08% | ₹1,534.23 |
| 2032 | ₹1,605.15 | +6.19% | ₹1,629.23 |
| 2033 | ₹1,754.51 | +9.3% | ₹1,780.83 |
| 2034 | ₹1,976.26 | +12.63% | ₹2,005.90 |
| 2035 | ₹2,012.37 | +1.82% | ₹2,042.56 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Amrutanjan Health Care Brief Company Overview
Amrutanjan Health Care Limited: A Legacy of Ayurvedic Wellness Established in 1893, Amrutanjan Health Care Limited is a renowned Indian company dedicated to providing holistic health solutions. With a diverse product portfolio, the company has carved a niche in the healthcare...
industry. **Key Products and Services:** Ayurvedic pain balms and roll-ons Congestion management products (cold rubs, cough syrups) Sanitary napkins for women Juice drinks under the Fruitnik brand Pain management center **Reputation and Market Presence:** Amrutanjan Health Care Limited has a strong reputation in the industry, with its products reaching consumers in various regions, including: Middle East Africa Southeast Asia Internationally **Commitment to Quality:** The company is committed to providing high-quality healthcare products, adhering to stringent manufacturing standards and ethical practices.Amrutanjan Health Care Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,926.88 Crore | Market valuation of Amrutanjan Health Care's shares. |
| Revenue (TTM) | 427.1 Crore | Total revenue generated by Amrutanjan Health Care over the past twelve months. |
| Net Income (TTM) | +42.57 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +2.34% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +9.96% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+7.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-34.21% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
0.59 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1.72 Crore | Sum of Amrutanjan Health Care's current & long-term financial obligations. |
| Total Cash | 211.31 Crore | Total amount of liquid funds available to Amrutanjan Health Care. |
| Beta | 0.74 | Beta is less than 1 indicating that the Amrutanjan Health Care's price is less volatile than the market. |
Is Amrutanjan Health Care A Good Buy For Long Term?
Amrutanjan Health Care, a small-cap stock with a market capitalization of ₹1,926.88 crore, presents a mixed picture for long-term investment. While its five-year return of 141.66% is impressive, the recent Q1 2024-25 results show a concerning 34.21% drop in earnings compared to the same quarter last year. Despite a healthy cash balance of ₹211.31 crore and low debt (₹1.72 crore), the declining profitability warrants caution. A 9.96% profit margin and positive YTD returns suggest potential, but further analysis is needed before classifying it as a good long-term buy. It's currently an average buy, pending further investigation.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
